1 Cardiohepatic Interactions in Heart Failure: An Overview and Clinical Implications JACC - Journal of the American College of Cardiology, April 26, 2013
2 Predictors of diabetic nephropathy Central European Journal of Medicine, April 23, 2013
3 Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Childrens Oncology Group phase 1 consortium study The Lancet Oncology, April 24, 2013
4 A risk for hepatocellular carcinoma still persists long-term after sustained virological response in patients with hepatitis C associated liver cirrhosis Clinical Infectious Diseases, April 26, 2013
5 Hepatic Dysfunction in Ambulatory Patients with Heart Failure - Application of the MELD Scoring System for Outcome Prediction JACC - Journal of the American College of Cardiology, April 26, 2013
6 Effect of Helicobacter pylori Infection on Esophagogastric Variceal Bleeding in Patients with Liver Cirrhosis and Portal Hypertension Journal of Gastroenterology and Hepatology, April 26, 2013
7 Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus Alimentary Pharmacology and Therapeutics, April 22, 2013
8 Improving Hepatocellular Carcinoma Screening: Applying Lessons From Colorectal Cancer Screening Clinical Gastroenterology and Hepatology , May 7, 2013
9 Expression of Apoptosis- and Vitamin D Pathway-Related Genes in Hepatocellular Carcinoma Digestion, May 3, 2013
10 Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study The Lancet Oncology, May 3, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor